| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Newhall Charles W III | Director | Sell | 3,588 | $45.01 | $161,495.88 | -2.7% | +2.2% | - | |
| Aug 27, 2025 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Sell | 8,415,414 | $0.00 | - | -9.1% | - | - | |
| Aug 27, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Kiely John | Director | Sell | 32,000 | $9.23 | $295,360.00 | -12.4% | +32.9% | - | |
| Aug 27, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 200,000 | $0.28 | $56,740.00 | -1.9% | - | - | |
| Aug 26, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 11,581 | $43.69 | $505,968.10 | -9.0% | -16.7% | - | |
| Aug 26, 2025 | PLNH Planet 13 Holdings Inc. | Groesbeck Robert | Co-ceo | Sell | 637,000 | $0.29 | $182,774.40 | -4.7% | - | - | |
| Aug 25, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 1,000 | $45.00 | $45,000.00 | - | +1.6% | - | |
| Aug 25, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Newhall Charles W III | Director | Sell | 1,000 | $45.00 | $45,000.00 | -0.7% | +1.6% | - | |
| Aug 25, 2025 | ANIP Ani Pharmaceuticals Inc | Leonard Matthew J | Director | Sell | 2,528 | $90.62 | $229,087.36 | -26.9% | -10.3% | - | |
| Aug 25, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Mottola Frank | SVP, Quality, Gmp, Ops, It | Sell | 14,000 | $44.51 | $623,140.00 | -47.5% | +1.6% | - | |
| Aug 25, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,571 | $44.53 | $114,486.63 | -1.7% | -12.1% | - | |
| Aug 25, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita53 | Executive Vice President | Sell | 120,832 | $9.65 | $1,166,222.72 | -28.8% | +30.9% | - | |
| Aug 22, 2025 | ELTP Elite Pharmaceuticals Inc /nv/ | Elite Pharmaceuticals Inc /nv/ | EVP Operations | Sell | 500,000 | $0.52 | $262,150.00 | -21.7% | - | - | |
| Aug 22, 2025 | EOLS Evolus, Inc. | Yamagishi-Dressler Tomoko74 | Chief Marketing Officer | Sell | 5,722 | $7.51 | $42,972.22 | -6.0% | -13.8% | - | |
| Aug 22, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Newhall Charles W III | Director | Sell | 1,412 | $45.00 | $63,540.00 | -1.0% | -0.2% | - | |
| Aug 22, 2025 | DVAX Dynavax Technologies Corp | Myers Scott Dunseth47 | Director | Buy | 3,800 | $10.82 | $41,116.00 | +12.2% | +2.9% | - | |
| Aug 22, 2025 | PRGO Perrigo Co Plc | Willis Robert55 | EVP &CHRO | Buy | 1,488 | $24.10 | $35,857.82 | +3.7% | -49.9% | - | |
| Aug 22, 2025 | CGC Canopy Growth Corp | Gedeon Christelle80 | See Remarks | Sell | 16,929 | $1.74 | $29,456.46 | -4.4% | -20.5% | - | |
| Aug 22, 2025 | CGC Canopy Growth Corp | Stewart Thomas Carlton45 | See Remarks | Sell | 5,768 | $1.74 | $10,036.32 | -7.8% | -20.5% | - | |
| Aug 22, 2025 | ANIP Ani Pharmaceuticals Inc | Davis Krista45 | SVP, Chief Hr Officer | Sell | 1,763 | $91.10 | $160,609.30 | -2.7% | -13.7% | - | |
| Aug 22, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Dec Timothy C | Senior Vice-president &CFO | Sell | 11,780 | $44.49 | $524,092.20 | -90.4% | -0.2% | - | |
| Aug 22, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 1,500 | $45.00 | $67,500.00 | -0.1% | -0.2% | - | |
| Aug 22, 2025 | JNJ Johnson & Johnson | Duato Joaquin | CEO And Chairman Of The Board | Sell | 125,824 | $179.21 | $22,548,654.81 | -31.3% | +13.3% | - | |
| Aug 22, 2025 | PLNH Planet 13 Holdings Inc. | Groesbeck Robert | Co-ceo | Sell | 641,000 | $0.28 | $181,232.20 | -4.3% | - | - | |
| Aug 22, 2025 | DVAX Dynavax Technologies Corp | Deep Track Biotechnology Master Fund, Ltd. | 10% Owner | Sell | 2,065,137 | $10.82 | $22,351,598.19 | -6.0% | +2.9% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.